Cunliffe Sean 4/A
4/A · ANGIOTECH PHARMACEUTICALS INC · Filed May 17, 2011
Insider Transaction Report
Form 4/AAmended
Cunliffe Sean
SVP, Sales & Marketing
Transactions
- Other
Common Stock
2011-05-12−70,700→ 0 total - Other
Stock Option w/Tandem SAR
2011-05-12−85,000→ 100,000 totalExercise: $1.05From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying) - Other
Stock Option w/Tandem SAR
2011-05-12−100,000→ 0 totalExercise: $1.28From: 2009-12-01Exp: 2014-11-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).